Skip to content

Testing a digital, comprehensive, standardised assessment approach to improve the management of people with cancer

MyPath – Developing and implementing innovative patient-centred care pathways for cancer patients: formative evaluation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15235259
Enrollment
500
Registered
2026-02-18
Start date
2025-12-08
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer

Interventions

Implementation of the MyPath digital solution for systematic symptom mapping in cancer patients. Patients will use the MyPath solution as part of their regular follow-up. They will record their sympt

Sponsors

Oslo University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Aged =18 years 2. Able to understand and speak the local language 3. Diagnosed with cancer 4. Able to provide informed consent

Exclusion criteria

Exclusion criteria: Potential participants will not be eligible if they have cognitive and or communication difficulties that would make a semi-structured interview/focus group discussion not possible

Countries

Belgium, Denmark, England, Italy, Netherlands, Norway, Romania, Scotland, Spain, United Kingdom

Contacts

Public ContactLisa Heide Koteng
likote@ous-hf.no+47 22 93 40 16

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026